pmid	doi	year	title	Hugo_Symbol
33078873	10.1002/gcc.22901	2022	Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience.	RUNX1
33368842	10.1002/gcc.22933	2022	Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia.	RUNX1
33890726	10.1002/cjp2.211	2022	CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.	RUNX1
34250504	10.1158/2643-3230.BCD-20-0229	2022	Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.	RUNX1
34325057	10.1016/j.jmoldx.2021.07.008	2022	Comparison of Two Quantitative PCR-Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts.	RUNX1
34348305	10.1159/000518280	2022	Cytogenetic and Fluorescence in situ Hybridization Profile of Pediatric Acute Lymphoblastic Leukemia in a University Hospital in South India.	RUNX1
34535762	10.1038/s41375-021-01409-9	2022	ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis.	RUNX1
34547766	10.1182/bloodadvances.2021004895	2022	Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.	RUNX1
34597466	10.1002/pbc.29361	2022	Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.	RUNX1
34601571	10.1182/blood.2021013156	2022	Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.	RUNX1
34617433	10.4274/tjh.galenos.2021.2021.0326	2022	Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian Patients	RUNX1
34698360	10.3892/ijo.2021.5274	2022	lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.	RUNX1
34727170	10.1182/bloodadvances.2021005522	2022	Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia.	RUNX1
34753926	10.1038/s41408-021-00570-9	2022	Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes.	RUNX1
34788984	10.3324/haematol.2021.279177	2022	Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.	RUNX1
34819303	10.1101/mcs.a006157	2022	Hi-C detects genomic structural variants in peripheral blood of pediatric leukemia patients.	RUNX1
34871373	10.1182/blood.2021012727	2022	Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.	RUNX1
34902205	10.1111/cas.15239	2022	RUNX1 transactivates BCR-ABL1 expression in Philadelphia chromosome positive acute lymphoblastic leukemia.	RUNX1
34933343	10.1182/bloodadvances.2021005634	2022	Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.	RUNX1
34940123	10.3390/cimb43030149	2022	Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression.	RUNX1
34974289	10.1016/j.cancergen.2021.12.003	2022	Somatic homozygous loss of SH2B3, and a non-Robertsonian translocation t(15;21)(q25.3;q22.1) with NTRK3 rearrangement, in an adolescent with progenitor B-cell acute lymphoblastic leukemia with the iAMP21.	RUNX1
34975010	10.1016/j.clml.2021.11.013	2022	Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia.	RUNX1
34981432	10.1007/s12185-021-03269-6	2022	Newly diagnosed ETV6-RUNX1-positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow.	RUNX1
34982829	10.1182/bloodadvances.2021005703	2022	A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins.	RUNX1
34998786	10.1016/j.clml.2021.12.008	2022	The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia.	RUNX1
34999180	10.1016/j.gene.2021.146132	2022	Identification of diagnosis and prognosis gene markers in B-ALL with ETV6-RUNX1 fusion by integrated bioinformatics analysis.	RUNX1
35004601	10.3389/fpubh.2021.805757	2022	Risk Factors for Childhood Leukemia: Radiation and Beyond.	RUNX1
35074994	10.4103/IJPM.IJPM_1154_20	2022	Erythrophagocytosis in a patient with B-cell acute lymphoblastic leukemia with t(12;21) (p13.2; q22.1); ETV6-RUNX1: Case report and review of the literature.	RUNX1
35084434	10.1001/jamaoncol.2021.6826	2022	Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.	RUNX1
35114276	10.1016/j.gene.2022.146234	2022	Oncogenic Runx1-Myc axis in p53-deficient thymic lymphoma.	RUNX1
35253299	10.1002/gcc.23036	2022	CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.	RUNX1
35255774	10.1080/15548627.2022.2048432	2022	TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss.	RUNX1
35258855	10.1007/s12185-022-03315-x	2022	JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia.	RUNX1
35290157	10.1080/10428194.2022.2047673	2022	Significance of <i>RUNX1</i> mutation in <i>BCR-ABL1</i> positive acute myeloid leukemia - a diagnostic dilemma in a young woman with persistent bleeding.	RUNX1
35294722	10.1007/s11864-022-00963-3	2022	In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia.	RUNX1
35379077	10.1080/10428194.2022.2057488	2022	Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy.	RUNX1
35380239	10.1007/s00277-022-04806-x	2022	The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.	RUNX1
35506873	10.1080/10428194.2022.2064991	2022	Apparent coexistence of <i>ETV6::RUNX1</i> and <i>KMT2A::MLLT3</i> fusions due to a nonproductive <i>KMT2A</i> rearrangement in B-ALL.	RUNX1
35533071	10.1080/10428194.2022.2067997	2022	Familial platelet disorder due to germline exonic deletions in <i>RUNX1</i>: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium.	RUNX1
35543621	10.1080/10428194.2022.2070913	2022	Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis.	RUNX1
35562965	10.3390/ijms23094574	2022	Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia.	RUNX1
35575404	10.1093/jnci/djac101	2022	Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia.	RUNX1
35644195	10.7499/j.issn.1008-8830.2111108	2022	[Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the <i>PRAME</i> gene].	RUNX1
35685993	10.21147/j.issn.1000-9604.2022.02.03	2022	Genomic landscape of T-cell lymphoblastic lymphoma.	RUNX1
35865523	10.3389/fimmu.2022.868053	2022	Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice.	RUNX1
35995457	10.1080/10428194.2022.2113524	2022	Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.	RUNX1
36011285	10.3390/genes13081374	2022	Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.	RUNX1
36045062	10.3343/alm.2023.43.1.92	2022	First Case of <i>ETV6-RUNX1</i> Fusion in Adult <i>De Novo</i> Acute Myeloid Leukemia Detected Using Targeted RNA Sequencing.	RUNX1
31385734	10.1080/10428194.2019.1648801	2021	Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited <i>RUNX1</i> mutations without a pre-existing platelet disorder.	RUNX1
31524018	10.1080/10428194.2019.1660975	2021	Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/<i>BCR-FGFR1</i>-rearranged myeloid/lymphoid neoplasm with <i>RUNX1</i> mutation - diagnostic pitfalls and clinical management including FGFR1 inhibitor pemigatinib.	RUNX1
31704777	10.1136/jmedgenet-2019-106339	2021	Novel phenotypes observed in patients with <i>ETV6</i>-linked leukaemia/familial thrombocytopenia syndrome and a biallelic <i>ARID5B</i> risk allele as leukaemogenic cofactor.	RUNX1
31894899	10.1002/cyto.b.21865	2021	CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases.	RUNX1
31944572	10.1002/cyto.b.21866	2021	CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.	RUNX1
31952221	10.3390/cells9010215	2021	<i>ETV6</i>/<i>RUNX1</i> Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia.	RUNX1
32013644	10.1080/10428194.2020.1719089	2021	Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes.	RUNX1
32091281	10.1080/10428194.2020.1723016	2021	Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated <i>RUNX1</i> versus acute myeloid leukemia with myelodysplasia-related changes with mutated <i>RUNX1</i>.	RUNX1
32118299	10.1111/bjh.16523	2021	Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche.	RUNX1
32150610	10.1182/bloodadvances.2019001008	2021	The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia.	RUNX1
32276273	10.1182/blood.2019003312	2021	E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.	RUNX1
32368831	10.1002/gcc.22858	2021	Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.	RUNX1
32378810	10.1002/cam4.3099	2021	High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.	RUNX1
32397113	10.3390/ijms21093323	2021	Identification of Lenalidomide Sensitivity and Resistance Mechanisms in Non-Del(5q) Myelodysplastic Syndromes.	RUNX1
32467145	10.3324/haematol.2020.247973	2021	Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.	RUNX1
32541834	10.1038/s41423-020-0429-4	2021	Pluripotent stem cell-derived CD19-CAR iT cells effectively eradicate B-cell lymphoma in vivo.	RUNX1
32573712	10.1182/blood.2019004090	2021	Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.	RUNX1
32579960	10.1016/j.bcp.2020.114116	2021	Inhibition of RUNX1 promotes cisplatin-induced apoptosis in ovarian cancer cells.	RUNX1
32614960	10.1182/blood.2020005879	2021	Oncogenesis by E2A-PBX1 in ALL: RUNX and more.	RUNX1
32651109	10.1016/j.clml.2020.05.020	2021	Childhood Therapy-Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall.	RUNX1
32693409	10.1182/blood.2020006164	2021	Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.	RUNX1
32757686	10.1080/10428194.2020.1798951	2021	Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>.	RUNX1
32812094	10.1007/s10561-020-09855-y	2021	Screening for pre-leukemia TEL-AML1 chromosomal translocation in banked cord blood units: cord blood bank perspective.	RUNX1
32836179	10.1016/j.anndiagpath.2020.151588	2021	Siblings with ETV6/RUNX1-positive B-lymphoblastic leukemia: A single site experience and review of the literature.	RUNX1
32868912	10.1038/s41423-020-00527-1	2021	Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution.	RUNX1
32898863	10.1182/blood.2020005622	2021	Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemia.	RUNX1
32911536	10.1182/blood.2019004381	2021	An intact gut microbiome protects genetically predisposed mice against leukemia.	RUNX1
32946981	10.1016/j.exphem.2020.09.184	2021	Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature.	RUNX1
33038982	10.1016/j.beha.2020.101193	2021	Molecular markers in ALL: Clinical implications.	RUNX1
33070555	10.4143/crt.2020.507	2021	Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia.	RUNX1
33074527	10.1007/s11684-020-0759-8	2021	Precision medicine in acute lymphoblastic leukemia.	RUNX1
33095873	10.1182/bloodadvances.2019001307	2021	Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.	RUNX1
33113607	10.3760/cma.j.issn.0253-2727.2020.09.008	2021	[Diagnosis of adult Philadelphia chromosome-like acute lymphoblastic leukemia by fluorescence in situ hybridization].	RUNX1
33161783	10.1080/10428194.2020.1832664	2021	Identification of two novel mutations in human acute myeloid leukemia cases.	RUNX1
33164984	10.1172/JCI140797	2021	Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo.	RUNX1
33170547	10.1111/ijlh.13386	2021	The gene expression level of m6A catalytic enzymes is increased in ETV6/RUNX1-positive acute lymphoblastic leukemia.	RUNX1
33225787	10.1080/10428194.2020.1849680	2021	AML1-ETO inhibits acute myeloid leukemia immune escape by CD48.	RUNX1
33245684	10.2217/epi-2020-0152	2021	Role of rs10406069 in miR-5196 in hyperdiploid childhood acute lymphoblastic leukemia.	RUNX1
33327998		2021	[Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds].	RUNX1
33328584	10.1038/s41568-020-00315-z	2021	Advances in germline predisposition to acute leukaemias and myeloid neoplasms.	RUNX1
33333691	10.3760/cma.j.issn.0253-2727.2020.11.003	2021	[Efficacy and prognostic factors of the chemotherapy regimen of CCLG-ALL-2008 on pediatric acute lymphoblastic leukemia with ETV6-RUNX1 rearrangement].	RUNX1
33355873	10.32471/exp-oncology.2312-8852.vol-42-no-4.15275	2021	Woman with Turner syndrome and her child with acute leukemia (a case report).	RUNX1
33386596	10.1007/s12185-020-03063-w	2021	The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia.	RUNX1
33400146	10.1007/s11684-020-0821-6	2021	Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.	RUNX1
33554816	10.19746/j.cnki.issn.1009-2137.2021.01.028	2021	[Characteristic of 8p11 Myeloproliferative Syndrome with Rare Phenotype].	RUNX1
33563056	10.1080/10428194.2021.1881503	2021	Searching for germline mutations in the <i>RUNX1</i> gene among Polish patients with acute myeloid leukemia.	RUNX1
33646306	10.1182/bloodadvances.2020001844	2021	Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.	RUNX1
33714976	10.1038/s41375-021-01209-1	2021	Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.	RUNX1
33725318	10.1007/s12185-021-03116-8	2021	Clinical features and chromosomal/genetic aberration in adult acute lymphoblastic leukemia in Japan: results of Fukuoka Blood &amp; Marrow Transplant Group Studies ALL MRD 2002 and 2008.	RUNX1
33739852	10.1200/JCO.20.02370	2021	Favorable Trisomies and <i>ETV6-RUNX1</i> Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331.	RUNX1
33743795	10.1186/s13045-021-01051-z	2021	Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.	RUNX1
33750258	10.1080/0284186X.2021.1900908	2021	Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on <i>BCR-ABL1</i>-like subtype.	RUNX1
33895809	10.1182/blood.2020010144	2021	Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.	RUNX1
33973643	10.5146/tjpath.2021.01524	2021	Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.	RUNX1
33983906	10.1172/JCI138833	2021	Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLL-rearranged B cell acute lymphoblastic leukemia.	RUNX1
33987955	10.1002/cam4.3928	2021	RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.	RUNX1
34010407	10.1182/blood.2020009895	2021	Toward prevention of childhood ALL by early-life immune training.	RUNX1
34027815	10.1080/10428194.2021.1929960	2021	<i>RUNX1</i> gene alterations characterized by allelic preference in adult acute myeloid leukemia.	RUNX1
34101758	10.1371/journal.pone.0253012	2021	Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.	RUNX1
34120331	10.1111/bjh.17569	2021	Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-RUNX1T1 transcripts.	RUNX1
34159401	10.1007/s00277-021-04574-0	2021	Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.	RUNX1
34266412	10.1186/s12885-021-08545-6	2021	DNA index as prognostic factor in childhood acute lymphoblastic leukemia in the COG-TARGET database.	RUNX1
34299194	10.3390/ijms22147576	2021	Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways.	RUNX1
34329606	10.1016/S1470-2045(21)00328-4	2021	Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.	RUNX1
34424323	10.1182/bloodadvances.2021004653	2021	B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations.	RUNX1
34511174	10.7499/j.issn.1008-8830.2105004	2021	Clinical features and prognosis of children with acute leukemias of ambiguous lineage under different diagnostic criteria.	RUNX1
34570179	10.1182/bloodadvances.2021004668	2021	Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.	RUNX1
34623329	10.1172/JCI152464	2021	To T or not to B: germline RUNX1 mutation preferences in pediatric ALL predisposition.	RUNX1
34732618	10.11406/rinketsu.62.1465	2021	[Down syndrome and acute lymphoblastic leukemia].	RUNX1
34963222	10.3760/cma.j.cn115330-20210125-00036	2021	[The role of RUNX1 in the apoptosis of epithelial cells in nasal polyps].	RUNX1
28487787	10.1155/2017/5083463	2020	EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in <i>ASXL1</i>, <i>BCOR</i>, <i>CDKN2A</i>, <i>NF1</i>, and <i>TP53</i>.	RUNX1
29316705	10.3390/cancers10010013	2020	Translocation Breakpoints Preferentially Occur in Euchromatin and Acrocentric Chromosomes.	RUNX1
29530508	10.1016/j.jim.2018.03.005	2020	Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.	RUNX1
30277115	10.1080/10428194.2018.1516876	2020	Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients.	RUNX1
30328750	10.1080/10428194.2018.1520991	2020	Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO.	RUNX1
30381299	10.3324/haematol.2018.193631	2020	Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.	RUNX1
30630978	10.3324/haematol.2018.204974	2020	Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.	RUNX1
30770347	10.1158/1055-9965.EPI-18-0801	2020	Is There Etiologic Heterogeneity between Subtypes of Childhood Acute Lymphoblastic Leukemia? A Review of Variation in Risk by Subtype.	RUNX1
30842058	10.1016/S1470-2045(19)30031-2	2020	Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia.	RUNX1
30986496	10.1016/j.exphem.2019.03.004	2020	ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.	RUNX1
30990344	10.1080/10428194.2019.1587756	2020	A novel germline <i>RUNX1</i> mutation with co-occurrence of somatic alterations in a case of myeloid neoplasm with familial thrombocytopenia: first report from India.	RUNX1
30997874	10.1080/10428194.2018.1522439	2020	RUNX1 mutations in MDS, s-AML, and de novo AML: differences in accompanying genetic alterations and outcome.	RUNX1
31028135	10.1042/BSR20190389	2020	ssExpression level of GAS6-mRNA influences the prognosis of acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation.	RUNX1
31034759	10.1002/pbc.27780	2020	High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.	RUNX1
31114350	10.2147/CMAR.S192845	2020	High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.	RUNX1
31243155	10.1126/scitranslmed.aat8549	2020	Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8<sup>+</sup> T cell responses.	RUNX1
31247675	10.1111/bjh.16080	2020	Negative CD19 expression is associated with inferior relapse-free survival in children with RUNX1-RUNX1T1-positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.	RUNX1
31289210	10.3324/haematol.2018.205849	2020	<i>TP53, ETV6</i> and <i>RUNX1</i> germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia.	RUNX1
31368255	10.1002/pbc.27951	2020	Acute myeloid leukemia arising after Hodgkin lymphoma in a patient with WHIM syndrome.	RUNX1
31381561	10.1371/journal.pgen.1008280	2020	PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.	RUNX1
31429529	10.1002/mgg3.933	2020	The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.	RUNX1
31456164	10.1007/s13353-019-00509-8	2020	MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL.	RUNX1
31602594	10.1007/s13353-019-00524-9	2020	The correction of ETV6/RUNX1 translocation in acute lymphocytic leukemia cells: a new gene targeting system by homologous recombination mechanism.	RUNX1
31623479	10.1080/10428194.2019.1675882	2020	Controversies about germline <i>RUNX1</i> missense variants.	RUNX1
31629941	10.1016/j.ejca.2019.09.004	2020	Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study.	RUNX1
31642380	10.1080/10428194.2019.1680843	2020	Reply to Brown et al: 'Correct application of variant classification guidelines in germline <i>RUNX1</i> mutated disorders to assist clinical diagnosis'.	RUNX1
31647332	10.1080/10428194.2019.1680842	2020	Correct application of variant classification guidelines in germline <i>RUNX1</i> mutated disorders to assist clinical diagnosis.	RUNX1
31648321	10.1182/bloodadvances.2019000404	2020	Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.	RUNX1
31767839	10.1038/s41467-019-13069-6	2020	Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.	RUNX1
31779973	10.1016/j.beha.2019.101095	2020	How advanced are we in targeting novel subtypes of ALL?	RUNX1
31817853	10.3390/ijms20246175	2020	SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric <i>ETV6-RUNX1</i> B-Acute Lymphoblastic Leukemia Patients.	RUNX1
31824864	10.3389/fonc.2019.01304	2020	Myeloid/Lymphoid Neoplasm With FGFR1 Rearrangement Accompanying <i>RUNX1</i> and <i>NOTCH1</i> Gene Mutations.	RUNX1
31869410	10.1182/bloodadvances.2019000925	2020	Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.	RUNX1
31896782	10.1038/s41375-019-0697-0	2020	The clinical mutatome of core binding factor leukemia.	RUNX1
31902036	10.1007/s10555-019-09841-1	2020	Insights into the prenatal origin of childhood acute lymphoblastic leukemia.	RUNX1
31965269	10.1007/s00277-020-03911-z	2020	Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax.	RUNX1
32029838	10.1038/s41598-020-58970-z	2020	Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia.	RUNX1
32078009	10.1007/s00277-020-03953-3	2020	Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.	RUNX1
32114371	10.1016/j.leukres.2020.106316	2020	Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1.	RUNX1
32135505	10.1016/j.canep.2020.101693	2020	MTHFR rs1801133 polymorphism is associated with increased risk of B-cell precursor lymphoblastic leukaemia with recurrent genetic aberrations of fetal origin.	RUNX1
32216001	10.1111/cas.14392	2020	Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34<sup>+</sup> cells under cytokine stimulation.	RUNX1
32536138	10.3760/cma.j.issn.0253-2727.2020.05.008	2020	[Clinical characteristics and gene expression profiles in children with ETV6-RUNX1 acute lymphoblastic leukemia].	RUNX1
32572036	10.1038/s41598-020-65744-0	2020	Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL.	RUNX1
33178996	10.21037/acr-19-168	2020	The primary pulmonary NUT carcinomas and some uncommon somatic mutations identified by next-generation sequencing: a case report.	RUNX1
27468869	10.4149/neo_2016_502	2019	Incidence of preleukemic fusion genes in healthy subjects.	RUNX1
28394181	10.1080/10428194.2017.1292357	2019	A novel recurrent copy number loss region on 6q23.3 in MDS-related myeloid malignancy patients with stable survival conditions.	RUNX1
28810325	10.3760/cma.j.issn.0253-2727.2017.07.006	2019	[Heterogeneity and clonal evolution in pediatric ETV6-RUNX1(+) acute lymphoblastic leukemia by quantitative multigene fluorescence in situ hybridization].	RUNX1
28954346	10.3760/cma.j.issn.0253-2727.2017.08.006	2019	[Clinical significance of monitoring ETV6-RUNX1 fusion gene expression in children with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].	RUNX1
28972594	10.1038/leu.2017.303	2019	RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.	RUNX1
29148893	10.1200/JCO.2017.74.4946	2019	Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).	RUNX1
29249175	10.1080/10428194.2017.1410882	2019	A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells.	RUNX1
29311095	10.1182/blood-2017-09-808402	2019	Five percent of healthy newborns have an <i>ETV6-RUNX1</i> fusion as revealed by DNA-based GIPFEL screening.	RUNX1
29407587	10.1016/j.leukres.2018.01.012	2019	High frequency of intermediate and poor risk copy number abnormalities in pediatric cohort of B-ALL correlate with high MRD post induction.	RUNX1
29491461	10.1038/s41417-018-0013-6	2019	Clinical and biological implications of mutational spectrum in acute myeloid leukemia of FAB subtypes M4 and M5.	RUNX1
29654272	10.1038/s41375-018-0110-4	2019	Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.	RUNX1
29666006	10.1016/j.cancergen.2018.01.002	2019	Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.	RUNX1
29674693	10.1038/s12276-018-0067-4	2019	Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.	RUNX1
29733873	10.1016/j.exphem.2018.04.008	2019	RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.	RUNX1
29748211	10.1158/1535-7163.MCT-17-1123	2019	Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4<sup>+</sup> Infant ALL.	RUNX1
29784935	10.1038/s41568-018-0015-6	2019	A causal mechanism for childhood acute lymphoblastic leukaemia.	RUNX1
29904089	10.1038/s41417-018-0028-z	2019	Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia.	RUNX1
29923177	10.1002/ijc.31622	2019	BMI1 enhancer polymorphism underlies chromosome 10p12.31 association with childhood acute lymphoblastic leukemia.	RUNX1
29967129	10.1182/blood-2018-02-832253	2019	Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.	RUNX1
29997224	10.1182/blood-2018-04-841676	2019	Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.	RUNX1
30005852	10.1016/j.cancergen.2018.05.004	2019	SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.	RUNX1
30006258	10.1016/j.clml.2018.06.017	2019	Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician.	RUNX1
30032569	10.3760/cma.j.issn.0253-2727.2018.06.013	2019	[Targeted sequencing analysis of hyper-eosinophilic syndrome and chronic eosinophilic leukemia].	RUNX1
30078801	10.11406/rinketsu.59.899	2019	[Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].	RUNX1
30115129	10.1186/s13052-018-0541-6	2019	ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol.	RUNX1
30125757	10.1016/j.leukres.2018.08.009	2019	Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia.	RUNX1
30150206	10.1182/blood-2018-05-849059	2019	Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.	RUNX1
30168245	10.1002/pbc.27366	2019	A triple-probe FISH screening strategy for risk-stratified therapy of acute lymphoblastic leukaemia in low-resource settings.	RUNX1
30487223	10.1073/pnas.1814397115	2019	Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.	RUNX1
30500954	10.1093/nar/gky756	2019	Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.	RUNX1
30510082	10.1182/blood-2018-07-862946	2019	Novel susceptibility variants at the <i>ERG</i> locus for childhood acute lymphoblastic leukemia in Hispanics.	RUNX1
30561492	10.1093/ajcp/aqy160	2019	Application of Fluorescence In Situ Hybridization on Cerebrospinal Fluid Cytospins for the Detection of Residual Leukemic Cells in Patients With Childhood Acute Lymphoblastic Leukemia.	RUNX1
30635552	10.1038/s12276-018-0195-x	2019	CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia.	RUNX1
30689137	10.1007/s12185-019-02599-w	2019	Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.	RUNX1
30695313		2019	[Case Conference of Hematological Malignancies Based on the Morphology of Blood Cells: Chairmen's Introductory Remarks].	RUNX1
30701458	10.1007/s11033-019-04649-2	2019	Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.	RUNX1
30701920	10.26442/terarkh201890730-37	2019	Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.	RUNX1
30730614	10.1111/ijlh.12983	2019	Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.	RUNX1
30809981	10.3343/alm.2019.39.4.358	2019	The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in <i>De Novo</i> Pediatric Acute Leukemias.	RUNX1
30944321	10.1038/s41467-019-09469-3	2019	Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia.	RUNX1
31157932	10.1002/bem.22193	2019	Novel ETV6-RUNX1 Mouse Model to Study the Role of ELF-MF in Childhood B-Acute Lymphoblastic Leukemia: a Pilot Study.	RUNX1
31385395	10.1111/cas.14160	2019	Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.	RUNX1
31506148		2019	[Long-term clinical effect of the CCLG-ALL2008 regimen in treatment of childhood acute lymphoblastic leukemia with different molecular biological features].	RUNX1
27056890	10.18632/oncotarget.8554	2018	Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model.	RUNX1
27220664	10.1038/leu.2016.152	2018	Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.	RUNX1
27265895	10.1038/ncomms11790	2018	Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.	RUNX1
27506214	10.4143/crt.2016.211	2018	Outcome and Prognostic Factors for <i>ETV6/RUNX1</i> Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea.	RUNX1
27590521	10.18632/oncotarget.11773	2018	Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.	RUNX1
27620872	10.1101/gr.193649.115	2018	Genome-wide repression of eRNA and target gene loci by the ETV6-RUNX1 fusion in acute leukemia.	RUNX1
27650541	10.18632/oncotarget.12063	2018	Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.	RUNX1
27736291	10.1080/10428194.2016.1243677	2018	Clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.	RUNX1
27931139	10.1080/10428194.2016.1265118	2018	Clinical characteristics and platelet phenotype in a family with RUNX1 mutated thrombocytopenia.	RUNX1
27967290	10.1080/10428194.2016.1266622	2018	Ecotropic viral integration site I regulates alpha1, 6-fucosyl transferase expression and blocks erythropoiesis in chronic myeloid leukemia.	RUNX1
28063722	10.1016/j.jfma.2016.12.002	2018	Concordance of two approaches in monitoring of minimal residual disease in B-precursor acute lymphoblastic leukemia: Fusion transcripts and leukemia-associated immunophenotypes.	RUNX1
28092997	10.1080/10428194.2016.1272690	2018	The t(8;21) fusion protein RUNX1-ETO downregulates PKM2 in acute myeloid leukemia cells.	RUNX1
28093006	10.1080/10428194.2016.1274980	2018	Blood malignancies presenting with mutations at equivalent residues in RUNX1-2 suggest a common leukemogenic pathway.	RUNX1
28415763	10.18632/oncotarget.16211	2018	Low numbers of pre-leukemic fusion genes are frequently present in umbilical cord blood without affecting DNA damage response.	RUNX1
28418909	10.18632/oncotarget.16367	2018	Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.	RUNX1
28446316	10.7534/j.issn.1009-2137.2017.02.050	2018	[Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].	RUNX1
28624474	10.1016/j.tiv.2017.06.013	2018	Exposure to the insecticides permethrin and malathion induces leukemia and lymphoma-associated gene aberrations in vitro.	RUNX1
28687222	10.1016/j.clml.2017.06.003	2018	TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.	RUNX1
28724437	10.1186/s12943-017-0692-x	2018	The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.	RUNX1
28806978	10.1186/s13045-017-0515-y	2018	Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.	RUNX1
28819864	10.1007/s00018-017-2620-z	2018	Molecular processes involved in B cell acute lymphoblastic leukaemia.	RUNX1
28853218	10.1002/pbc.26786	2018	Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic/cytogenetic features in children with B-precursor acute lymphoblastic leukemia.	RUNX1
28933515	10.1002/hon.2269	2018	B-cell lymphoblastic lymphoma presenting as solitary temporal mass with amplification of AML1/RUNX1: case report.	RUNX1
29025715	10.1182/blood-2017-08-802181	2018	RUNX1 in T-ALL: tumor suppressive or oncogenic?	RUNX1
29064485	10.1038/leu.2017.289	2018	Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.	RUNX1
29067751	10.1111/ped.13440	2018	Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia.	RUNX1
29105243	10.1111/ped.13451	2018	Multiplex fusion gene testing in pediatric acute myeloid leukemia.	RUNX1
29119847	10.1080/10428194.2017.1397663	2018	Myeloid/lymphoid neoplasms with FGFR1 rearrangement.	RUNX1
29290585	10.1016/j.devcel.2017.12.005	2018	A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.	RUNX1
29589281	10.1007/s12185-018-2440-4	2018	Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.	RUNX1
29632299	10.1038/s41467-018-03178-z	2018	Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.	RUNX1
29696374	10.1007/s00277-018-3331-8	2018	BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.	RUNX1
29763473	10.1371/journal.pone.0197408	2018	Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia.	RUNX1
29778230	10.1016/j.cancergen.2018.03.001	2018	ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis.	RUNX1
29950197	10.7534/j.issn.1009-2137.2018.03.002	2018	[HER2 Expression in Childhood ETV6/RUNX1<sup>+</sup> Acute Lymphoblastic Leukemia and Its Correlation with Clinical Features].	RUNX1
29961066	10.1159/000491065	2018	Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.	RUNX1
26327566	10.3109/10428194.2015.1088650	2017	Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia.	RUNX1
26374622	10.3109/10428194.2015.1094698	2017	Identification and functional analysis of acute myeloid leukemia susceptibility associated single nucleotide polymorphisms at non-protein coding regions of RUNX1.	RUNX1
26429121	10.4081/pmc.2015.112	2017	Mitotic crossover promotes leukemogenesis in children born with TEL-AML1 via the generation of loss of heterozygosity at 12p.	RUNX1
26707936	10.1038/leu.2015.353	2017	CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.	RUNX1
26871368	10.1080/10245332.2015.1106816	2017	Fusion genes in malignant neoplastic disorders of haematopoietic system.	RUNX1
26883104	10.18632/oncotarget.7356	2017	Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes.	RUNX1
26910834	10.18632/oncotarget.7489	2017	High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia.	RUNX1
26919255	10.18632/oncotarget.7687	2017	Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.	RUNX1
26957068	10.3760/cma.j.issn.0578-1310.2016.03.011	2017	[Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia].	RUNX1
27033238	10.3324/haematol.2015.141101	2017	New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.	RUNX1
27106701	10.1007/s00277-016-2678-y	2017	Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.	RUNX1
27151989	10.3324/haematol.2016.143875	2017	Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.	RUNX1
27161658	10.1016/j.jmoldx.2016.03.004	2017	Genome-Wide Single-Nucleotide Polymorphism Array Analysis Improves Prognostication of Acute Lymphoblastic Leukemia/Lymphoma.	RUNX1
27210295	10.1016/j.clml.2016.04.001	2017	Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).	RUNX1
27215399	10.1016/j.yexmp.2016.05.010	2017	Oligo-based aCGH analysis reveals cryptic unbalanced der(6)t(X;6) in pediatric t(12;21)-positive acute lymphoblastic leukemia.	RUNX1
27239736	10.1016/j.leukres.2016.05.009	2017	Defining the significance of IGF2BP1 overexpression in t(12;21)(p13;q22)-positive leukemia REH cells.	RUNX1
27341996	10.1016/j.cancergen.2016.06.004	2017	Chromosomal aberrations in childhood acute lymphoblastic leukemia: 15-year single center experience.	RUNX1
27365488	10.3324/haematol.2016.147496	2017	Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia.	RUNX1
27374714	10.3343/alm.2016.36.5.475	2017	Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.	RUNX1
27393278	10.1007/s12185-016-2034-y	2017	Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.	RUNX1
27431763	10.7554/eLife.13087	2017	Transcription-coupled genetic instability marks acute lymphoblastic leukemia structural variation hotspots.	RUNX1
27521317	10.1016/j.clml.2016.02.032	2017	Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic Leukemia.	RUNX1
27536776	10.1371/journal.pone.0161539	2017	Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia.	RUNX1
27560110	10.1038/leu.2016.234	2017	Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.	RUNX1
27611867	10.1371/journal.pone.0162638	2017	The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia.	RUNX1
27632978	10.1186/s13000-016-0541-z	2017	Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.	RUNX1
27664585	10.1016/j.gene.2016.09.030	2017	Characterization of a novel acquired der(1)del(1)(p13p31)t(1;15)(q42;q15) in a high risk t(12;21)-positive acute lymphoblastic leukemia.	RUNX1
27683100	10.1002/cncr.30257	2017	The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.	RUNX1
27698447	10.1038/leu.2016.274	2017	Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children.	RUNX1
27725192	10.1016/j.exphem.2016.09.013	2017	AML1-ETO promotes SIRT1 expression to enhance leukemogenesis of t(8;21) acute myeloid leukemia.	RUNX1
27770540	10.1002/ijc.30481	2017	A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.	RUNX1
27802191	10.3233/CBM-160656	2017	Molecular combing: A new tool in diagnosing leukemia.	RUNX1
27869314	10.1002/jcb.25802	2017	Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis.	RUNX1
28004528	10.1111/ijlh.12593	2017	Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.	RUNX1
28028313	10.1038/leu.2016.392	2017	Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.	RUNX1
28028966	10.17219/acem/63752	2017	Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia.	RUNX1
28063196	10.1002/gcc.22443	2017	ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.	RUNX1
28063378	10.1016/j.leukres.2016.12.005	2017	Overexpression of PTP4A3 in ETV6-RUNX1 acute lymphoblastic leukemia.	RUNX1
28085746	10.1097/MPH.0000000000000770	2017	Cytogenetic and Cytogenomic Microarray Characterization of Chromothripsis in Chromosome 8 Affecting MOZ/NCOA2 (TIF2), FGFR1, RUNX1T1, and RUNX1 in a Pediatric Acute Myeloid Leukemia.	RUNX1
28202519	10.1158/0008-5472.CAN-16-2571	2017	Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia.	RUNX1
28270453	10.1182/blood-2016-09-742148	2017	Activation of the <i>LMO2</i> oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.	RUNX1
28299660	10.1007/978-981-10-3233-2_14	2017	ETV6-RUNX1 <sup>+</sup> Acute Lymphoblastic Leukaemia in Identical Twins.	RUNX1
28349830	10.1177/1010428317694308	2017	Aberrant AML1 gene expression in the diagnosis of childhood leukemias not characterized by AML1-involved cytogenetic abnormalities.	RUNX1
28376129	10.1371/journal.pone.0175122	2017	LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation.	RUNX1
28395118	10.1002/gcc.22464	2017	ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.	RUNX1
28408464	10.1182/blood-2016-12-758979	2017	Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.	RUNX1
28476192	10.1016/j.arcmed.2016.12.005	2017	Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.	RUNX1
28476198	10.1016/j.arcmed.2016.12.002	2017	Copy Number Alterations Associated with Acute Lymphoblastic Leukemia in Mexican Children. A report from The Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia.	RUNX1
28500740	10.1002/pbc.26518	2017	Children with low-risk acute lymphoblastic leukemia are at highest risk of second cancers.	RUNX1
28555414	10.1007/s12185-017-2259-4	2017	Germline ETV6 mutations and predisposition to hematological malignancies.	RUNX1
28557976	10.1038/bjc.2017.152	2017	Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.	RUNX1
28600336	10.1182/blood-2017-02-734541	2017	Diagnosis and classification of hematologic malignancies on the basis of genetics.	RUNX1
28630052	10.1158/0008-5472.CAN-17-0701	2017	Infection Exposure Promotes <i>ETV6-RUNX1</i> Precursor B-cell Leukemia via Impaired H3K4 Demethylases.	RUNX1
28709134	10.1016/j.ejca.2017.06.012	2017	BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.	RUNX1
28778863	10.1182/blood-2017-05-742643	2017	New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia.	RUNX1
28790107	10.1182/blood-2017-03-775536	2017	RUNX1 is required for oncogenic <i>Myb</i> and <i>Myc</i> enhancer activity in T-cell acute lymphoblastic leukemia.	RUNX1
29125853	10.1371/journal.pone.0187422	2017	Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL).	RUNX1
29153092	10.1016/j.cancergen.2017.08.005	2017	Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?	RUNX1
25645650	10.1111/ejh.12515	2016	The molecular pathogenesis of the myelodysplastic syndromes.	RUNX1
25764068	10.1371/journal.pone.0119256	2016	Neonatal infection with species C adenoviruses confirmed in viable cord blood lymphocytes.	RUNX1
25893288	10.1038/onc.2015.50	2016	The TEL-AML1 fusion protein of acute lymphoblastic leukemia modulates IRF3 activity during early B-cell differentiation.	RUNX1
26001080	10.1371/journal.pone.0127460	2016	Central Role of Core Binding Factor β2 in Mucosa-Associated Lymphoid Tissue Organogenesis in Mouse.	RUNX1
26137961	10.3324/haematol.2015.126953	2016	CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.	RUNX1
26237075	10.1080/15592294.2015.1061174	2016	Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.	RUNX1
26266519	10.1007/s40291-015-0149-0	2016	High frequency and poor prognosis of late childhood BCR-ABL-positive and MLL-AF4-positive ALL define the need for advanced molecular diagnostics and improved therapeutic strategies in pediatric B-ALL in Pakistan.	RUNX1
26269126	10.1186/s12885-015-1586-1	2016	Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5(+/-) leukemia.	RUNX1
26297264	10.1016/j.clml.2015.02.035	2016	Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia.	RUNX1
26316320	10.1038/leu.2015.236	2016	Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.	RUNX1
26514535	10.7314/apjcp.2015.16.16.7343	2016	Importance of FISH combined with Morphology, Immunophenotype and Cytogenetic Analysis of Childhood/ Adult Acute Lymphoblastic Leukemia in Omani Patients.	RUNX1
26520622	10.1016/j.leukres.2015.10.006	2016	Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.	RUNX1
26580398	10.1371/journal.pone.0142863	2016	A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.	RUNX1
26625756	10.7314/apjcp.2015.16.17.7523	2016	Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission.	RUNX1
26628061	10.1111/bjh.13861	2016	Identification of novel biomarkers in chronic immune thrombocytopenia (ITP) by microarray-based serum protein profiling.	RUNX1
26670384	10.1128/mBio.01863-15	2016	Common Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas.	RUNX1
26693794	10.3109/10428194.2015.1115041	2016	Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.	RUNX1
26697989	10.1016/j.critrevonc.2015.11.004	2016	Myeloproliferative neoplasms: Current molecular biology and genetics.	RUNX1
26711002	10.1002/cam4.579	2016	Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.	RUNX1
26781410		2016	[Detection of copy number variations in pediatric ETV6/RUNX1-positive acute lymphoblastic leukemia with multiplex ligation-dependent probe amplification].	RUNX1
26785729	10.1074/mcp.M115.054593	2016	High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.	RUNX1
26852652	10.1016/j.bcmd.2015.11.006	2016	ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.	RUNX1
26907657	10.1097/MPH.0000000000000545	2016	RUNX1 Amplification Increases the Risk for Thrombosis in Children With B-cell Acute Lymphoblastic Leukemia.	RUNX1
23772668	10.3109/10428194.2013.815351	2015	RUNX1-ETO induces a type I interferon response which negatively effects t(8;21)-induced increased self-renewal and leukemia development.	RUNX1
24144310	10.3109/10428194.2013.855311	2015	Identification of target genes using gene expression profile of granulocytes from patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.	RUNX1
24188477	10.3109/10428194.2013.861071	2015	Clinical outcome of the coexistence of ETV6/RUNX1 and high hyperdiploidy in pediatric acute lymphoblastic leukemia.	RUNX1
24241490	10.3324/haematol.2012.072470	2015	Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.	RUNX1
24286261	10.3109/10428194.2013.869327	2015	Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature.	RUNX1
24790906	10.3343/alm.2014.34.3.198	2015	Diagnostic utility of multiprobe fluorescence in situ hybridization assay for detecting cytogenetic aberrations in acute leukemia.	RUNX1
24816234	10.3324/haematol.2014.103820	2015	IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia.	RUNX1
24897505	10.1038/leu.2014.177	2015	Evolutionary trajectories of hyperdiploid ALL in monozygotic twins.	RUNX1
24957142	10.1182/blood-2014-03-562918	2015	A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia.	RUNX1
25137060	10.1371/journal.pone.0104419	2015	Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL), a new method to detect translocations in leukemia.	RUNX1
25150625	10.1016/j.bcmd.2014.07.011	2015	Concordant B-cell precursor acute lymphoblastic leukemia in non-twinned siblings.	RUNX1
25273558	10.1091/mbc.E14-06-1038	2015	Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.	RUNX1
25312094	10.1111/bjh.13142	2015	Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia.	RUNX1
25355294	10.1002/humu.22719	2015	The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing.	RUNX1
25388957	10.1038/leu.2014.322	2015	Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.	RUNX1
25431866	10.1055/s-0034-1387795	2015	Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.	RUNX1
25444907	10.1016/j.canlet.2014.11.024	2015	Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.	RUNX1
25678190	10.1016/j.cancergen.2014.11.003	2015	Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.	RUNX1
25692130	10.1155/2014/210560	2015	Prevalence of gene rearrangements in Mexican children with acute lymphoblastic leukemia: a population study-report from the Mexican Interinstitutional Group for the identification of the causes of childhood leukemia.	RUNX1
25873510	10.1309/AJCPUD6W1JLQQMNA	2015	Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.	RUNX1
25948177	10.7534/j.issn.1009-2137.2015.02.004	2015	[Cytogenetic characteristics of 163 children with acute lymphoblastic leukemia].	RUNX1
25982135	10.1002/pbc.25583	2015	Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi-institutional report from Pakistan.	RUNX1
26071468	10.1309/AJCPLUYF11HQBYRB	2015	Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.	RUNX1
26185316	10.1309/AJCPVY5E5OMMYBFJ	2015	Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic Leukemia.	RUNX1
26189108	10.1016/j.leukres.2015.06.005	2015	Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.	RUNX1
26304079	10.3760/cma.j.issn.0253-2727.2015.07.008	2015	[A case report of childhood acute lymphoblastic leukemia with intrachromosomal amplification of AML1 gene in chromosome 21 and TEL deletion].	RUNX1
23190578	10.1111/ijlh.12031	2014	Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.	RUNX1
23210573	10.3109/10428194.2012.754888	2014	Detection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia.	RUNX1
23488608	10.3109/10428194.2013.786068	2014	The ETV6/RUNX1 fusion transcript is not detected in RNA isolated from neonatal dried blood spots from children later diagnosed with the corresponding leukemia.	RUNX1
23636228	10.1038/leu.2013.136	2014	Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor.	RUNX1
23672346	10.3109/10428194.2013.801469	2014	Acute myeloid leukemia with a novel t(8;21) variant: paracentric inversion-associated ins(21;8).	RUNX1
23679839	10.1111/cas.12199	2014	Roles of AML1/RUNX1 in T-cell malignancy induced by loss of p53.	RUNX1
23692290	10.1111/ejh.12147	2014	Concomitant germ-line RUNX1 and acquired ASXL1 mutations in a T-cell acute lymphoblastic leukemia.	RUNX1
23713453	10.3109/10428194.2013.805759	2014	Clinical significance of lymphoid enhancer-binding factor 1 expression in acute myeloid leukemia.	RUNX1
23716539	10.3324/haematol.2012.080432	2014	Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts.	RUNX1
23722552	10.1158/0008-5472.CAN-12-4367	2014	Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia.	RUNX1
23826571	10.3343/alm.2013.33.4.304	2014	The utility of the multiplex reverse transcriptase-polymerase chain reaction assay in the detection of hematologic malignancies.	RUNX1
23911702	10.3324/haematol.2013.090225	2014	High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.	RUNX1
23940019	10.1002/pbc.24584	2014	Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study.	RUNX1
23940220	10.1200/JCO.2013.48.9377	2014	Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.	RUNX1
23940221	10.1200/JCO.2013.49.1308	2014	Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.	RUNX1
24006408	10.3324/haematol.2013.090860	2014	Clone-specific secondary aberrations are not detected in neonatal blood spots of children with ETV6-RUNX1-positive leukemia.	RUNX1
24045615	10.1093/hmg/ddt447	2014	Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.	RUNX1
24052438	10.1007/s13277-013-1192-2	2014	Applicability of gene expression profile of childhood acute lymphoblastic leukemia at diagnosis and at the end of the induction phase of chemotherapy at a cancer hospital in the state of Goiás (Brazil).	RUNX1
24076604	10.1038/ng.2777	2014	Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia.	RUNX1
24123676	10.1002/gcc.22105	2014	Identification of a novel fusion gene involving RUNX1 and the antisense strand of SV2B in a BCR-ABL1-positive acute leukemia.	RUNX1
24140475	10.1016/j.cellsig.2013.09.021	2014	New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.	RUNX1
24166298	10.1038/leu.2013.317	2014	An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.	RUNX1
24222333	10.1182/blood-2013-06-509463	2014	Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.	RUNX1
24231528	10.1016/j.leukres.2013.10.008	2014	Significance of CD66c expression in childhood acute lymphoblastic leukemia.	RUNX1
24235135	10.1182/blood-2013-07-453480	2014	How I treat ALL in Down's syndrome: pathobiology and management.	RUNX1
24240203	10.1038/leu.2013.345	2014	Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia.	RUNX1
24319172	10.1182/asheducation-2013.1.118	2014	Targeting signaling pathways in acute lymphoblastic leukemia: new insights.	RUNX1
24327541	10.1002/gcc.22124	2014	The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.	RUNX1
24339741	10.1593/neo.131310	2014	ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.	RUNX1
24394348	10.4161/epi.27585	2014	Epigenetic deregulation in pediatric acute lymphoblastic leukemia.	RUNX1
24413735	10.1038/ng.2874	2014	RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.	RUNX1
24473322	10.1038/ng.2879	2014	A RAG driver on the road to pediatric ALL.	RUNX1
24557455	10.1159/000356778	2014	ETV6/RUNX1 rearrangement identified by RT-PCR without evidence on FISH.	RUNX1
24574234	10.1002/art.38264	2014	Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome.	RUNX1
24596209	10.1158/2159-8290.CD-RW2014-018	2014	ETV6-RUNX1-positive ALL may be driven by aberrant RAG activity.	RUNX1
24648275	10.1002/pbc.25031	2014	Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA).	RUNX1
24740533	10.1002/pbc.25050	2014	False positivity of ETV6/RUNX1 detected by FISH in healthy newborns and adults.	RUNX1
24792891	10.1016/j.gene.2014.04.074	2014	RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells.	RUNX1
24898268	10.1124/jpet.114.214742	2014	3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways.	RUNX1
24998463	10.1016/j.cancergen.2014.05.003	2014	High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.	RUNX1
25043025	10.1038/nature13393	2014	Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.	RUNX1
25394790	10.1126/science.1259037	2014	Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.	RUNX1
22359517	10.1371/journal.pgen.1002533	2013	The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution.	RUNX1
22528566	10.1007/s12253-012-9533-9	2013	Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia.	RUNX1
22580999	10.3324/haematol.2011.059584	2013	Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.	RUNX1
22699455	10.1038/leu.2012.155	2013	Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.	RUNX1
22705992	10.1038/leu.2012.161	2013	Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.	RUNX1
22828445	10.1038/leu.2012.211	2013	EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.	RUNX1
22897724	10.3109/10428194.2012.710330	2013	Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia.	RUNX1
22976839	10.1007/s10552-012-0060-5	2013	NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution.	RUNX1
22994759	10.7314/apjcp.2012.13.7.3349	2013	Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.	RUNX1
23022380	10.1016/j.molcel.2012.08.022	2013	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	RUNX1
23077088	10.1002/gcc.22021	2013	Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.	RUNX1
23086478	10.1038/nm.2960	2013	NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species.	RUNX1
23135987	10.1002/stem.1277	2013	TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice.	RUNX1
23171811	10.1159/000342490	2013	Variant of ETV6/ABL1 gene is associated with leukemia phenotype.	RUNX1
23233609	10.1182/asheducation-2012.1.389	2013	The molecular genetic makeup of acute lymphoblastic leukemia.	RUNX1
23298878	10.1097/MOH.0b013e32835d82fe	2013	Polycythemia vera and essential thrombocythemia: new developments in biology with therapeutic implications.	RUNX1
23317202	10.7314/apjcp.2012.13.11.5469	2013	Five most common prognostically important fusion oncogenes are detected in the majority of Pakistani pediatric acute lymphoblastic leukemia patients and are strongly associated with disease biology and treatment outcome.	RUNX1
23341344	10.1002/gcc.22039	2013	The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.	RUNX1
23352661	10.1016/j.celrep.2012.12.016	2013	RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction.	RUNX1
23443342	10.1038/leu.2013.15	2013	Initially disadvantaged, TEL-AML1 cells expand and initiate leukemia in response to irradiation and cooperating mutations.	RUNX1
23491079	10.1016/j.cancergen.2013.01.004	2013	Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.	RUNX1
23694795		2013	Hemophagocytosis by leukemic blasts in B lymphoblastic leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): a case report.	RUNX1
23704093	10.1182/blood-2013-01-480244	2013	Runx1 is essential at two stages of early murine B-cell development.	RUNX1
23741012	10.1182/blood-2012-11-465252	2013	STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia.	RUNX1
23857984	10.1084/jem.20122516	2013	The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.	RUNX1
23859904	10.1016/j.cancergen.2013.05.017	2013	Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.	RUNX1
23915977	10.1016/j.leukres.2013.06.027	2013	MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.	RUNX1
24081948	10.1084/jem.20130497	2013	Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.	RUNX1
21569007	10.1111/j.1365-2141.2011.08729.x	2012	Native ETV6 deletions accompanied by ETV6-RUNX1 rearrangements are associated with a favourable prognosis in childhood acute lymphoblastic leukaemia: a candidate for prognostic marker.	RUNX1
21749308	10.3109/10428194.2011.594927	2012	A novel t(7;21)(q32;q22) translocation disrupting the RUNX1 gene in an adult patient with acute myeloid leukemia.	RUNX1
21822204	10.1038/modpathol.2011.118	2012	Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases.	RUNX1
21828118	10.3324/haematol.2011.043919	2012	Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.	RUNX1
21869842	10.1038/leu.2011.227	2012	ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.	RUNX1
21877899	10.3109/10428194.2011.618235	2012	Update on cytogenetic and molecular changes in myelodysplastic syndromes.	RUNX1
21914494	10.1016/j.exphem.2011.08.014	2012	hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.	RUNX1
22005784	10.1038/leu.2011.274	2012	High concordance of subtypes of childhood acute lymphoblastic leukemia within families: lessons from sibships with multiple cases of leukemia.	RUNX1
22015773	10.1038/leu.2011.278	2012	Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia.	RUNX1
22028862	10.1371/journal.pone.0026348	2012	The leukemia-specific fusion gene ETV6/RUNX1 perturbs distinct key biological functions primarily by gene repression.	RUNX1
22058208	10.3324/haematol.2011.049593	2012	Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity.	RUNX1
22076464	10.1038/leu.2011.302	2012	Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia.	RUNX1
22094584	10.1038/leu.2011.333	2012	Whole-exome sequencing of pediatric acute lymphoblastic leukemia.	RUNX1
22094587	10.1038/leu.2011.322	2012	Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts.	RUNX1
22145956	10.3109/10428194.2011.647314	2012	Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia.	RUNX1
22163048	10.1371/journal.pone.0028638	2012	Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.	RUNX1
22215484	10.1007/s12185-011-0981-x	2012	Childhood B-cell progenitor acute lymphoblastic leukemia presenting a three-way t(11;12;21)(q14;p13;q22) with a RUNX1 gene signal on chromosome 11.	RUNX1
22217495	10.1097/MPH.0b013e3182332268	2012	RT-PCR screening for ETV6-RUNX1-positive clones in cord blood from newborns in the Danish National Birth Cohort.	RUNX1
22226019	10.1016/j.leukres.2011.12.003	2012	RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina.	RUNX1
22237106	10.1038/nature10725	2012	The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.	RUNX1
22260162	10.3109/10428194.2012.658570	2012	Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan.	RUNX1
22362744	10.1093/nar/gks175	2012	MicroRNA and transcription factor co-regulatory network analysis reveals miR-19 inhibits CYLD in T-cell acute lymphoblastic leukemia.	RUNX1
22366949	10.1038/nm.2610	2012	Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.	RUNX1
22373549	10.1007/s00277-012-1431-4	2012	Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia.	RUNX1
22382891	10.1038/leu.2012.26	2012	Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries.	RUNX1
22404039	10.1111/j.1365-2141.2012.09083.x	2012	Genome-wide analysis of cytogenetic aberrations in ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia.	RUNX1
22449370	10.1016/j.disamonth.2012.01.011	2012	Adult acute leukemia.	RUNX1
22450142	10.1556/OH.2012.29334	2012	[Leukemia- and lymphoma-associated flow cytometric, cytogenetic, and molecular genetic aberrations in healthy individuals].	RUNX1
22514921		2012	[Radiation associated leukemia and myelodysplastic syndrome].	RUNX1
22521551	10.1016/j.leukres.2012.03.024	2012	Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol.	RUNX1
22531296	10.4161/epi.20193	2012	A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia.	RUNX1
22569278	10.1097/MCD.0b013e32835431fd	2012	One in 10 million: a case of cleidocranial dysplasia and acute lymphoblastic leukaemia--more than just a coincidence?	RUNX1
22748822	10.1016/j.leukres.2012.05.019	2012	Expression of RUNX1 isoforms and its target gene BLK in childhood acute lymphoblastic leukemia.	RUNX1
22897851	10.1016/j.ccr.2012.06.007	2012	Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.	RUNX1
22912405	10.1073/pnas.1200037109	2012	Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.	RUNX1
19698265		2011	[Aml1 gene abnormality in pediatric acute leukemia-review].	RUNX1
20713965	10.1182/blood-2010-05-282764	2011	Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonates.	RUNX1
20807887	10.1182/blood-2009-02-206706	2011	TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a.	RUNX1
20846103	10.3109/10428194.2010.503821	2011	Identification and molecular characterization of a novel 3&amp;#x2032; mutation in RUNX1 in a family with familial platelet disorder.	RUNX1
20880108	10.1111/j.1365-2141.2010.08370.x	2011	Childhood B-cell precursor acute lymphoblastic leukaemia in a patient with familial thrombocytopenia and RUNX1 mutation.	RUNX1
20958258	10.2174/1386207311107010036	2011	OPLS-DA as a suitable method for selecting a set of gene transcripts discriminating RAS- and PTPN11-mutated cells in acute lymphoblastic leukaemia.	RUNX1
21054152	10.3109/10428194.2010.522286	2011	RUNX1-MTG16 fusion gene in de novo acute myeloblastic leukemia with t(16;21)(q24;q22).	RUNX1
21145270	10.1016/j.bcmd.2010.11.003	2011	Febrile infections in young children do not frequently induce translocation ETV6-RUNX1.	RUNX1
21152005	10.1371/journal.pcbi.1001019	2011	Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells.	RUNX1
21160474	10.1038/nature09650	2011	Genetic variegation of clonal architecture and propagating cells in leukaemia.	RUNX1
21172890	10.1200/JCO.2010.32.0325	2011	Improved prognosis for older adolescents with acute lymphoblastic leukemia.	RUNX1
21212293	10.1182/blood-2010-09-309070	2011	ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia.	RUNX1
21224468	10.1182/blood-2010-03-275347	2011	ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.	RUNX1
21249144	10.1371/journal.pone.0016171	2011	Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.	RUNX1
21414819	10.1016/j.bcmd.2011.02.005	2011	Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.	RUNX1
21425961	10.3109/10428194.2011.566391	2011	Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia.	RUNX1
21444869	10.1200/JCO.2010.32.5340	2011	Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.	RUNX1
21482711	10.1182/blood-2010-10-314674	2011	Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia.	RUNX1
21487021	10.1093/hmg/ddr159	2011	Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy.	RUNX1
21527530	10.1182/blood-2011-01-329961	2011	Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.	RUNX1
21549623	10.1016/j.bcmd.2011.04.003	2011	PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.	RUNX1
21628403	10.1182/blood-2011-02-338848	2011	Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice.	RUNX1
21657952	10.3109/10428194.2011.576286	2011	A complex karyotype masked a cryptic variant t(8;21)(q22;q22) in a child with acute myeloid leukemia.	RUNX1
21705495	10.1182/blood-2010-12-326199	2011	HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.	RUNX1
21738341	10.3346/jkms.2011.26.7.886	2011	Spectra of chromosomal aberrations in 325 leukemia patients and implications for the development of new molecular detection systems.	RUNX1
18928518	10.1186/1756-8722-1-17	2010	Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.	RUNX1
19710699	10.1038/leu.2009.170	2010	Characterizing chromosomal break points of t(12;21)[ETV6-RUNX1]-positive leukaemia using multiple tiling PCR on whole-genome-amplified DNA.	RUNX1
19713226	10.3324/haematol.2009.011346	2010	Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.	RUNX1
19890372	10.1038/leu.2009.208	2010	Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.	RUNX1
19893343	10.3343/kjlm.2009.29.5.371	2010	[Clinical utility of fluorescence in-situ hybridization profile test in detecting genetic aberrations in acute leukemia].	RUNX1
19896186	10.1016/j.leukres.2009.09.033	2010	CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.	RUNX1
19927343	10.1002/jcla.20343	2010	AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia.	RUNX1
19998443	10.1002/gcc.20736	2010	Cytogenetics of long-term survivors of ETV6-RUNX1 fusion positive acute lymphoblastic leukemia.	RUNX1
20001230	10.3109/10428190903350397	2010	Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia.	RUNX1
20001241	10.3109/10428190903456967	2010	RUNX1 amplification in B-cell acute lymphoblastic leukemia.	RUNX1
20016529	10.1038/leu.2009.264	2010	Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.	RUNX1
20016538	10.1038/leu.2009.248	2010	Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.	RUNX1
20042721	10.1182/blood-2009-09-235986	2010	Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?	RUNX1
20061556	10.1182/blood-2009-10-251413	2010	Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia.	RUNX1
20197715	10.3343/kjlm.2010.30.1.1	2010	[Prognostic significance of TEL/AML1 rearrangement and its additional genetic changes in Korean childhood precursor B-acute lymphoblastic leukemia].	RUNX1
20211010	10.1186/1755-8794-3-6	2010	Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.	RUNX1
20409752	10.1016/S1470-2045(10)70066-8	2010	Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.	RUNX1
20442364	10.1182/blood-2009-07-235291	2010	Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.	RUNX1
20513752	10.1093/hmg/ddq224	2010	The correlation pattern of acquired copy number changes in 164 ETV6/RUNX1-positive childhood acute lymphoblastic leukemias.	RUNX1
20538338	10.1016/j.leukres.2010.05.012	2010	Folylpolyglutamate synthetase gene transcription is regulated by a multiprotein complex that binds the TEL-AML1 fusion in acute lymphoblastic leukemia.	RUNX1
20549580	10.1007/s12185-010-0612-y	2010	T cell acute lymphoblastic leukemia arising from familial platelet disorder.	RUNX1
20561032	10.1111/j.1600-0609.2010.01493.x	2010	Childhood near-tetraploid acute lymphoblastic leukemia: an EGIL study on 36 cases.	RUNX1
20587518	10.1158/0008-5472.CAN-10-0726	2010	Runx regulation of sphingolipid metabolism and survival signaling.	RUNX1
20594594	10.1016/j.leukres.2010.05.033	2010	Old drug--new insights--better treatment?	RUNX1
20620598	10.1016/j.cancergencyto.2010.04.010	2010	Distribution of common genetic subgroups in childhood acute lymphoblastic leukemia in four developing countries.	RUNX1
20658612	10.1002/pbc.22628	2010	Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in far east than west.	RUNX1
20686504	10.1038/leu.2010.155	2010	Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.	RUNX1
20701601	10.1111/j.1365-2141.2010.08314.x	2010	Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster study group.	RUNX1
20930648	10.1097/MPH.0b013e3181ed1655	2010	Multiplex reverse transcription-polymerase chain reaction as diagnostic molecular screening of 4 common fusion chimeric genes in Taiwanese children with acute lymphoblastic leukemia.	RUNX1
18728978	10.1080/08880010802237450	2009	RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.	RUNX1
19100516	10.1016/j.cancergencyto.2008.09.005	2009	ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.	RUNX1
19129484	10.1189/jlb.0808469	2009	Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.	RUNX1
19151769	10.1038/leu.2008.350	2009	Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis.	RUNX1
19403666	10.1128/JVI.00216-09	2009	Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.	RUNX1
19665068	10.1016/j.cancergencyto.2009.04.021	2009	ETV6-RUNX1 fusion gene and additional genetic changes in infant leukemia: a genome-wide analysis.	RUNX1
19837270	10.1016/j.cancergencyto.2009.06.013	2009	Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.	RUNX1
17956600	10.1186/1471-2164-8-385	2008	Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.	RUNX1
18202291	10.1126/science.1150648	2008	Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.	RUNX1
18206538	10.1016/j.cancergencyto.2007.10.004	2008	Multiple copies of RUNX1: description of 14 new patients, follow-up, and a review of the literature.	RUNX1
18445843	10.1200/JCO.2007.14.3552	2008	Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.	RUNX1
18539581	10.1556/OH.2008.28388	2008	[Intrachromosomal amplification of AML1 gene in childhood acute lymphoblastic leukemia].	RUNX1
18635414	10.1016/S1607-551X(08)70155-4	2008	TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.	RUNX1
18767146	10.1002/gcc.20613	2008	The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1.	RUNX1
16386788	10.1016/j.leukres.2005.11.007	2007	The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression.	RUNX1
16673018	10.1038/sj.leu.2404249	2007	A novel TEL-AML1 fusion transcript involving the pro-apoptotic gene BCL-G in pediatric precursor B acute lymphoblastic leukemia.	RUNX1
17673463	10.1074/jbc.M706314200	2007	Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation.	RUNX1
17690704	10.1038/sj.leu.2404879	2007	Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region.	RUNX1
17889709	10.1016/j.cancergencyto.2007.05.019	2007	Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.	RUNX1
17889714	10.1016/j.cancergencyto.2007.06.015	2007	RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia.	RUNX1
15970674	10.4161/cc.4.8.1860	2006	TELAML1-positive ALL: a discordant genotype.	RUNX1
16278392	10.1158/1078-0432.CCR-05-1239	2006	Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.	RUNX1
16307024	10.1038/sj.leu.2404028	2006	Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.	RUNX1
16914570	10.1158/1078-0432.CCR-05-2592	2006	CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.	RUNX1
17015828	10.1073/pnas.0603349103	2006	TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.	RUNX1
15704129	10.1002/gcc.20158	2005	ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.	RUNX1
15991223	10.1002/hon.734	2005	Increased expression of AML1-a and acquired chromosomal abnormalities in childhood acute lymphoblastic leukemia.	RUNX1
16213368	10.1016/j.cancergencyto.2005.02.020	2005	The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL).	RUNX1
14523475	10.1038/sj.leu.2403140	2004	Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.	RUNX1
15061191	10.1080/1042819031000139611	2004	Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.	RUNX1
15104277	10.1016/s0165-4608(03)00259-0	2004	Chromosome 21 tandem repetition and AML1 (RUNX1) gene amplification.	RUNX1
15104290	10.1016/j.cancergencyto.2003.07.003	2004	Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.	RUNX1
15142881	10.1182/blood-2003-12-4306	2004	Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis.	RUNX1
12002768	10.1080/10428190290012155	2003	Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome.	RUNX1
12526921	10.1016/s0145-2126(02)00183-2	2003	TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.	RUNX1
12072207	10.1016/s0165-4608(01)00633-1	2002	A new translocation that rearranges the AML1 gene in a patient with T-cell acute lymphoblastic leukemia.	RUNX1
12091359	10.1182/blood.v100.2.640	2002	Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal.	RUNX1
12393286	10.1016/s0165-4608(02)00566-6	2002	AML1 amplification in a case of childhood acute lymphoblastic leukemia.	RUNX1
7761424	10.1073/pnas.92.11.4917	1995	Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.	RUNX1
7780150		1995	The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.	RUNX1
